Accelerator update, OncoSwab in the news, sharing progress, and more!
November 2023 Newsletter
Welcome to our very first newsletter!
If you received this email, it’s because you’re part of a hand-picked list of individuals who have been a part of this journey, one way or another.
As we continue to grow and evolve, we decided to create this monthly newsletter so you can keep track of all the ups & downs we go through (mostly the ups ).
We would also like to take this moment to thank you all for your continuous support. OncoSwab is where it is because of the incredible community we have built, and we can’t wait to watch it grow further.
Hope you enjoy the read!
-Andrea & Pablo
The Accelerators are accelerating
Finalizing Health Wildcatters accelerator:
Earlier this year, OncoSwab was selected as one of ten promising startups to join the Health Wildcatters Accelerator.
Throughout this program, we've benefited from weekly pitch practices and personalised mentorship, connecting us with over 200 seasoned professionals spanning diverse industries, such as investors, business development experts, commercialization specialists, and healthcare professionals. We’ve done great progress and are deeply appreciative of the invaluable guidance we've received from a remarkable group of experts, and can’t wait to share our progress on Demo Day in just a few days!
If you’re in Dallas, join us at Pegasus Park on Tuesday, November 14th! Sign up to save your spot here.
OncoSwab is accepted into renowned Swiss MedTech Accelerator
We have achieved an extraordinary milestone by being selected as one of only 4 startups awarded the DayOne – MedTech Accelerator Prize for groundbreaking medical innovations! Only companies with a high potential to boost the economy in Switzerland and leverage the biotech ecosystem are accepted.
This achievement allows us to access to non-dilutive and in kind-funding, mentorship, and to be part of the Switzerland Innovation Park in the Basel-Jura area.
We’re currently lining up grant opportunities and working with the Swiss law firm BRAUNPAT to file a provisional patent in the upcoming days, sponsored by the DayOne Tech program.
OncoSwab Takes a Deep Dive into Market Research with I-Corps
No matter how good a product is, there’s no business without clients. And while we are aware that the lack of lung cancer screening is a real, undeniable problem, it’s our mission as founders to develop a strong go-to-market strategy.
Our participation in the U.S. National Science Foundation's Regional Innovation Corps (i-Corps) program is helping us get there. Our objectives are to have a deeper understanding of the market and engage with key stakeholders by performing customer interviews with healthcare providers, payors and patients.
Thanks to i-Corps, we've conducted 19 insightful interviews so far and learned about needs and preferences in cancer diagnostics.
We’ve been busy networking
OncoSwab was among the 30 finalists between 207 applicants selected to participate in Founder Pitch Week, which aims to reduce disparities in venture capital by giving diverse founders a spotlight. We couldn't be more thrilled to give a well-deserved shoutout to Bridgette Smith, former Google executive, angel investor and the incredible force behind Founder Pitch Week. Thanks to Bridgette's vision and meticulous planning, we had the opportunity to connect with multiple angel investors who showed a keen interest in supporting our mission.
Watch the interview of our CEO with Bridgette here.
Video: Founder Pitch Week - CEO of OncoSwab Interview
MedTech Conference (Delemont, Switzerland)
In line with our commitment to expand our research initiatives in Switzerland, the MedTech conference played a pivotal role in facilitating meaningful engagements with key local stakeholders from esteemed institutions such as the University of Basel and the University of Bern. Additionally, it provided us with valuable insights into the various funding opportunities that Switzerland has in store for us.
Advocating for women's leadership in innovation is close to our hearts. In late September, we participated in the Women’s Venture Summit in San Diego, where we connected with other female founders and investors advocating for reducing disparities in venture capital. Thanks to Dr. Silvia Mah and the Stella team for organizing WVS, we look forward to going again next year!
Jesse Draper, Cheryl Contee, Alicia Hanf, Geri Stengel and Julie Castro Abrams discuss women in Venture Capital and share their stories.
Lung Cancer Awareness Month
Andrea attended the Lung Cancer Initiative's #EveningOfHope Gala to celebrate #LungCancerAwarenessMonth and raise funds for lung cancer this past week in Raleigh, NC!
Luanne & Tom Stelten are active members of the Lung Cancer Initiative in North Carolina.
OncoSwab is getting more traction and visibility. Our participation in Health Wildcatters and DayOne Tech has helped us with our outreach activities. Find some of the pieces below:
Switzerland Innovation News
Our involvement in Switzerland has been featured on Radio RFJ (Canton of Jura), the newspaper Le Quotidien Jurassien and on Canal Alpha TV.
Dr. Pablo Lara, Chief Scientific Officer and co-founder of OncoSwab, receives DayOne Tech Accelerator Prize in the name of the company.
Medium‘s Authority Magazine interviews our CEO
Andrea Stephany shares her journey as the Co-founder of OncoSwab with Medium, known for its recognition of human stories and groundbreaking ideas. In the article, our CEO shares valuable lessons for aspiring entrepreneurs such as avoiding confirmation bias, actively listening in interviews, and being discerning when receiving advice.
Health Wildcatters Spotlight
OncoSwab involvement in Health Wildcatters was also highligehted in local news. Read here the articles from D Magazine and MedCityNews!
Introductions to accredited investors & angel groups: are you interested in joining the early stages of a biotech startup or know anyone who might be? Please respond to this email and we’ll get in touch with you!
Connections to healthcare providers: we are actively looking to collaborate with healthcare providers (particularly GPs, pulmonologists and oncologists) to understand their unique needs and preferences. If you're a healthcare provider, or if you know one who might be interested in sharing their insights, please let us know.